Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VVivos Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Vivos Therapeutics, Inc.

$0.16Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $5.15M. Net result −$5.52M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $5.15M. Running result $5.15M. Appliances: $640K. Billing Intelligence Services: $129K. Myofunctional Therapy Services: $337K. Sleep Testing Services: $2.39M. Sponsorship Seminar Other: $161K. Tooth Positioners: $715K. Treatment Centers: $767K. VIP: $12K.
  • Cost of revenue: −$2.2M. Running result $2.95M.
  • Gross profit: $2.95M. Running result $2.95M.
  • General and administrative: −$7.11M. Running result −$4.16M.
  • Sales and marketing: −$155K. Running result −$4.32M.
  • Depreciation and amortization: −$510K. Running result −$4.83M.
  • Operating income: −$4.83M. Running result −$4.83M.
  • Other expense: −$698K. Running result −$5.52M.
  • Pre-tax loss: −$5.52M. Running result −$5.52M.
  • Income tax benefit: $0. Running result −$5.52M.
  • Net loss: −$5.52M. Running result −$5.52M.